Market Whales and Their Recent Bets on VRTX Options
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors are showing a bullish sentiment towards Vertex Pharmaceuticals (VRTX) through significant options activity. The options activity includes 6 call options and 3 put options, with a price range focus between $400 and $500. The stock is currently trading at $483.59, down by 3.04%. Analysts have mixed ratings with target prices ranging from $425 to $541.
October 18, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Vertex Pharmaceuticals sees significant bullish options activity, with 6 call options and 3 put options, indicating investor confidence. The stock is currently down 3.04% at $483.59, with analysts' target prices ranging from $425 to $541.
The significant options activity, particularly the higher number of call options, suggests a bullish sentiment among investors. Despite the current price drop, the focus on a price range of $400-$500 indicates expectations of upward movement. Analysts' target prices also support potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100